Name
D2A2 - Cancer
Date & Time
Tuesday, May 27, 2025, 3:30 PM - 5:30 PM
Location Name
Hall A
Description
3:30 pm - 3:35 pm
Chair: Landon Edgar
3:35 pm - 4:10 pm
Keynote Speaker: Dr. Jennifer Munkley
4:10 pm - 4:35 pm
Invited Speaker: Dr. Heinz Läubli
Enhancing Cancer Immunotherapy by Targeting Cancer-Associated Glycans
4:35 pm - 5:00 pm
Invited Speaker: Dr. Kelly McNagny
5:00 pm - 5:15 pm
Oral Abstract: Dr. Mathieu Decloquement
Deciphering Siglec ligands in cancer to improve immunotherapy
5:15 pm - 5:30 pm
Oral Abstract: Dr. Rita Nehmé
Development of Galectin-7 and Galectin-1-Specific Inhibitors: Immunotherapy and Molecular Imaging in Triple-Negative Breast Cancer
Speakers
Dr. Jennifer Munkley, Newcastle University
Dr. Heinz Läubli, University of Basel
Dr. Kelly McNagny, University of British Columbia
Dr. Heinz Läubli, University of Basel
Dr. Kelly McNagny, University of British Columbia


